A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients.

Autor: Erken R; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Meibergdreef 9, Amsterdam, the Netherlands., Loukachov VV; Department of Experimental Immunology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., de Niet A; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Jansen L; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Stelma F; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Helder JT; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Peters MW; Department of Gastroenterology and Hepatology, Amsterdam UMC, Location AMC, Meibergdreef 9, 1105AZ, Amsterdam, the Netherlands., Zaaijer HL; Sanquin Blood Supply Foundation, Plesmanlaan 125, Amsterdam, the Netherlands., Kootstra NA; Department of Experimental Immunology, Amsterdam UMC, Amsterdam Infection & Immunity Institute, University of Amsterdam, Amsterdam, the Netherlands., Willemse SB; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Meibergdreef 9, Amsterdam, the Netherlands., Reesink HW; Amsterdam UMC, University of Amsterdam, Department of Gastroenterology and Hepatology, Amsterdam Gastroenterology Endocrinology Metabolism, Meibergdreef 9, Amsterdam, the Netherlands.

Publikováno v: Journal of clinical and experimental hepatology [J Clin Exp Hepatol] 2022 May-Jun; Vol. 12 (3), pp. 735-744. Date of Electronic Publication: 2022 Jan 04.

Immune phenotype and function of NK and T cells in chronic hepatitis C patients who received a single dose of anti-miR-122, RG-101

Autor: Stelma, F, van der Ree, MH, Sinnige, MJ, Brown, AC, Swadling, LJ, de Vree, JM, Willemse, SB, van der Valk, M, Grint, P, Neben, S, Klenerman, P, Barnes, E, Kootstra, NA, Reesink, HW

MicroRNA-122 (miR-122) is an important host factor for the hepatitis C (HCV) virus. Treatment with RG-101, a GalNAc conjugated anti-miR-122 oligonucleotide, resulted in a significant viral load reduction in patients with chronic hepatitis C (CHC) inf

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::30224e3e80f9aaf4a50a30c194fffea3
https://doi.org/10.1002/hep.29148

Systematic review with network meta-analysis: sustained hepatitis B surface antigen clearance after pegylated interferon cessation.

Autor: Zhang Y; Department of Hepatology, Hepatology Research Institute, the First Affiliated Hospital.; Department of Hepatology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital., Lin X; Department of Hepatology, Hepatology Research Institute, the First Affiliated Hospital.; Department of Hepatology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital., Wu H; Department of Medical Administration, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Chen J; Department of Hepatology, Hepatology Research Institute, the First Affiliated Hospital.; Department of Hepatology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital., Zheng Q; Department of Hepatology, Hepatology Research Institute, the First Affiliated Hospital.; Department of Hepatology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital.

Publikováno v: European journal of gastroenterology & hepatology [Eur J Gastroenterol Hepatol] 2024 Oct 01; Vol. 36 (10), pp. 1159-1170. Date of Electronic Publication: 2024 Jul 22.

The Observed Effect of Gastric Bypass Surgery on Direct-acting Antiviral Treatment: a Case Report.

Autor: Smolders EJ; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands., Willemse SB; Department of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, the Netherlands., El-Sherif O; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Khoo S; Institute of Translational Medicine, University of Liverpool, Liverpool, United Kingdom., Burger DM; Department of Pharmacy, Radboud University Medical Center, Nijmegen, the Netherlands.

Publikováno v: Annals of hepatology [Ann Hepatol] 2018 May-June; Vol. 17 (3), pp. 525-529. Date of Electronic Publication: 2018 Apr 09.

Immune responses in DAA treated chronic hepatitis C patients with and without prior RG-101 dosing.

Autor: van der Ree MH; Dep. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands; Dep. of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Stelma F; Dep. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands; Dep. of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Willemse SB; Dep. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands., Brown A; Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, UK., Swadling L; Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, UK., van der Valk M; Dep. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands; Dep. of Internal Medicine, Division of Infectious Diseases, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, Amsterdam, The Netherlands., Sinnige MJ; Dep. of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., van Nuenen AC; Dep. of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., de Vree JML; Dep. of Gastroenterology and Hepatology, University Medical Center Groningen, The Netherlands., Klenerman P; Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, UK., Barnes E; Nuffield Department of Medicine and the Oxford NIHR BRC, University of Oxford, Oxford, UK., Kootstra NA; Dep. of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands., Reesink HW; Dep. of Gastroenterology and Hepatology, Academic Medical Center, Amsterdam, The Netherlands; Dep. of Experimental Immunology, Academic Medical Center, Amsterdam, The Netherlands. Electronic address: h.w.reesink@amc.uva.nl.

Publikováno v: Antiviral research [Antiviral Res] 2017 Oct; Vol. 146, pp. 139-145. Date of Electronic Publication: 2017 Aug 24.